Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin

Erik Vegt, Jack F.M. Wetzels, Frans G.M. Russel, Rosalinde Masereeuw, Otto C. Boerman, Juliette E. van Eerd, Frans H.M. Corstens and Wim J.G. Oyen
Journal of Nuclear Medicine March 2006, 47 (3) 432-436;
Erik Vegt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jack F.M. Wetzels
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frans G.M. Russel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosalinde Masereeuw
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto C. Boerman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juliette E. van Eerd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frans H.M. Corstens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim J.G. Oyen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    %ID (mean ± SD) of 111In-OCT over time in kidneys at baseline or after infusion of GELO. Significantly less 111In-OCT was retained in kidneys after GELO infusion than after normal saline infusion (P = 0.006 for difference in areas under curves).

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    %ID (mean ± SD) of 111In-OCT over time in kidneys at baseline or after infusion of HES. No statistically significant difference was observed between infusion of normal saline and infusion of HES.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    Posterior images of kidney region 24 h after injection of 111In-OCT at baseline (A) and after GELO infusion (B) and at baseline (C) and after HES infusion (D). GELO resulted in renal uptake levels lower than those at baseline, whereas HES had no effect.

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    Clearance of 111In-OCT from blood over time. No statistically significant differences were observed between groups.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (3)
Journal of Nuclear Medicine
Vol. 47, Issue 3
March 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin
Erik Vegt, Jack F.M. Wetzels, Frans G.M. Russel, Rosalinde Masereeuw, Otto C. Boerman, Juliette E. van Eerd, Frans H.M. Corstens, Wim J.G. Oyen
Journal of Nuclear Medicine Mar 2006, 47 (3) 432-436;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin
Erik Vegt, Jack F.M. Wetzels, Frans G.M. Russel, Rosalinde Masereeuw, Otto C. Boerman, Juliette E. van Eerd, Frans H.M. Corstens, Wim J.G. Oyen
Journal of Nuclear Medicine Mar 2006, 47 (3) 432-436;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Glypican-3-Targeting F(ab')2 for 89Zr PET of Hepatocellular Carcinoma
  • Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
  • Reducing Renal Uptake of Radiolabeled Peptides Using Albumin Fragments
  • Bispecific Antibody Pretargeting of Radionuclides for Immuno-Single-Photon Emission Computed Tomography and Immuno-Positron Emission Tomography Molecular Imaging: An Update
  • Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides
  • Inhibition of Kidney Uptake of Radiolabeled Somatostatin Analogs: Amino Acids or Gelofusine?
  • Reply: Inhibition of Kidney Uptake of Radiolabeled Somatostatin Analogs: Amino Acids or Gelofusine?
  • Google Scholar

More in this TOC Section

  • Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
  • Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
  • The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma
Show more CLINICAL INVESTIGATIONS

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire